Autoimmune progesterone dermatitis (APD ... has classified this disorder as a rare disease, meaning less than 200,000 cases have ever been reported. The NIH's Office of Rare Diseases indicated ...
The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for autoimmune diseases, with chimeric antigen receptor (CAR)-T therapies ...
Vyvgart Hytrulo (efgartigimod alfa/hyaluronidase) is the first drug in the FcRn blocker class to treat CIDP, a rare autoimmune disease of the peripheral nervous system that causes fatigue ...